查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587416

生物皮肤替代市场规模、份额、趋势分析报告：按类型、应用、最终用途、地区、细分市场预测，2025-2030 年

Biological Skin Substitutes Market Size, Share & Trends Analysis Report By Type, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

生物皮肤替代市场成长与趋势

根据Grand View Research, Inc最新报告，预计到2030年，全球生物皮肤替代市场规模将达到57,908万美元，2025年至2030年复合年增长率为8.88%。

皮肤病患病率的增加、慢性病和创伤性紧急情况的发病率增加以及对组织工程和潜在研发线产品的认识不断增强是推动组织奈米转染技术发展的一些关键因素。此外，政府和私人组织对研发活动的投资增加预计将推动对生物皮肤替代的需求。

虚拟助理的流行正在影响创伤护理过程的多个方面，包括创伤护理就诊的遵守情况、虚拟护理平台和远端医疗的使用，以及帮助患者进行伤口包扎的社会支持，例如媒体平台上的影片串流。引发了增强的自助伤口敷料方法。人们越来越渴望了解健康的社会方面如何影响创伤护理患者的生活品质 (QoL) 和结果。由于医疗保健领域的这些变化，创伤护理的连续性在多个方面受到了破坏。然而，这些变化不仅对伤口结果产生负面影响，而且还推动了开发基于虚拟的患者就诊方法。

市场上的主要企业正在寻求透过升级产品、采取重大合作以及考虑收购和政府批准来改善其产品组合、扩大客户群并占领生物皮肤替代市场的更大份额。

生物皮肤替代市场报告亮点

  • 按类型划分，人类供体组织衍生产品细分市场占据最大市场占有率，2024 年将达到 67.42%。
  • 从应用来看，由于慢性伤口盛行率不断增加，预计在预测期内，慢性伤口细分市场将以 9.13% 的复合年增长率增长最快。
  • 按最终用途划分，医院细分市场在生物皮肤替代市场中占据主导地位，到 2024 年，其销售份额将达到 54.97%。由于等待时间减少和更灵活的调度选项，门诊病人设施领域预计在预测期内的复合年增长率将达到 8.9%。
  • 由于该地区有主要企业的存在，2024 年北美地区的收益占有率最大，接近 41.25%。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 生物替代皮肤变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 生物替代皮肤分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章生物皮肤替代市场：細項分析，按类型，2018-2030（百万美元）

  • 定义和范围
  • 2024 年及 2030 年类型市场占有率分析
  • 2018-2030 年全球生物皮肤替代市场（按类型）
  • 2018-2030年市场规模、预测与趋势分析

第五章生物皮肤替代市场：細項分析，按应用，2018-2030（百万美元）

  • 定义和范围
  • 2024 年和 2030 年应用市场占有率分析
  • 全球生物皮肤替代市场（按应用），2018-2030
  • 2018-2030年市场规模、预测与趋势分析

第六章生物皮肤替代市场：細項分析，按最终用途，2018-2030（百万美元）

  • 定义和范围
  • 2024 年及 2030 年最终用途市场占有率分析
  • 全球生物皮肤替代市场（按最终用途），2018-2030 年
  • 2018-2030年市场规模、预测与趋势分析

第七章生物皮肤替代市场：区域、估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
  • 主要市场参与企业的最新趋势和影响分析
  • 2024 年企业市场占有率分析
  • 主要企业简介
    • Organogenesis Inc.
    • Integra LifeSciences Corporation
    • Smith+Nephew
    • Tissue Regenix
    • MIMEDX Group, Inc.
    • Essity Aktiebolag（publ）（Essity Health & Medical）
    • Stryker
    • Vericel Corporation
    • 3M
    • BioTissue
Product Code: GVR-4-68040-040-0

Biological Skin Substitutes Market Growth & Trends:

The global biological skin substitutes market size is expected to reach USD 579.08 million by 2030 and is expected to expand at a CAGR of 8.88% from 2025 to 2030 based on a new report by Grand View Research, Inc. The increasing prevalence of skin diseases, rising incidence of chronic diseases & trauma emergencies, and increasing consciousness regarding tissue engineering, along with potential pipeline products, are some of the major factors responsible for the growth of tissue nano transfection technology. Furthermore, increasing government and private organizations' investment in research and development activities is likely to boost the demand for biological skin substitutes.

The COVID-19 pandemic has affected several aspects of the wound care process, which includes compliance with wound care visits, triggering alternative approaches such as the use of virtual care platforms or telemedicine and streaming videos on the social media platform to assist the patients with wound dressing and empowering a do-it-yourself wound dressing approach. There is an increasing desire to understand how the social dimensions of health impact the Quality of Life (QoL) and effectiveness of wound care patients. The direct consequence of such changes in health care is the disruption of the continuity of wound care in several ways. However, these changes have negatively impacted wound outcomes but also have driven the development of a virtual-based approach for patient visits.

The key companies in the market are attempting to improve their portfolio by upgrading their products, employing significant cooperative efforts, and considering acquisitions and government permissions to increase their client base and capture a larger share of the biological skin substitutes market.

Biological Skin Substitutes Market Report Highlights:

  • Based on type, the human donor tissue-derived products segment accounted for the largest market share of 67.42% in 2024 as it allows better integration and acceptance by the patient's body
  • Based on application, the chronic wounds segment is expected to witness the fastest growth, with a CAGR of 9.13% over the forecast period due to the increasing prevalence of chronic wounds
  • Based on end-use, the hospital segment dominated the biological skin substitutes market with a revenue share of 54.97% in 2024. The outpatient facilities segment is expected to witness the fastest CAGR of 8.9% over the forecast period owing to the shorter wait times and more flexible scheduling options
  • North America accounted for the largest revenue share of nearly 41.25% in 2024 owing to the presence of major companies in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Applications
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Biological Skin Substitute Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Chronic Diseases
      • 3.2.1.2. Technological Advancements In Biological Skin Substitutes
      • 3.2.1.3. Rising Geriatric Population
      • 3.2.1.4. Increasing Surgical Procedures
      • 3.2.1.5. Growing Burn And Trauma Cases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost Of Skin Substitute Products
      • 3.2.2.2. Regulatory Hurdles
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing Demand For Aesthetic Procedures
      • 3.2.3.2. Expansion In Emerging Markets
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Intense Competition
  • 3.3. Biological Skin Substitute Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Biological Skin Substitute Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2030
  • 4.3. Global Biological Skin Substitute Market, by Type, 2018 to 2030
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.4.1. Human Donor Tissue -derived Products
      • 4.4.1.1. Human Donor Tissue-derived Products, 2018 - 2030 (USD Million)
    • 4.4.2. Acellular Animal-derived Products
      • 4.4.2.1. Acellular Animal-derived Products, 2018 - 2030 (USD Million)

Chapter 5. Biological Skin Substitute Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2024 & 2030
  • 5.3. Global Biological Skin Substitute Market, by Application, 2018 to 2030
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.4.1. Acute Wounds
      • 5.4.1.1. Acute Wounds market, 2018 - 2030 (USD Million)
    • 5.4.2. Chronic Wounds
      • 5.4.2.1. Chronic Wounds market, 2018 - 2030 (USD Million)

Chapter 6. Biological Skin Substitute Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2030
  • 6.3. Global Biological Skin Substitute Market, by End Use, 2018 to 2030
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.4.1. Hospitals
      • 6.4.1.1. Hospitals market, 2018 - 2030 (USD Million)
    • 6.4.2. Outpatient facilities
      • 6.4.2.1. Outpatient facilities market, 2018 - 2030 (USD Million)
    • 6.4.3. Research and manufacturing
      • 6.4.3.1. Research and manufacturing market, 2018 - 2030 (USD Million)

Chapter 7. Biological Skin Substitute Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Recent Developments & Impact Analysis by Key Market Participants
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Key Company Profiles
    • 8.4.1. Organogenesis Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Integra LifeSciences Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Smith+Nephew
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Tissue Regenix
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. MIMEDX Group, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Essity Aktiebolag (publ))( Essity Health & Medical)
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Stryker
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Vericel Corporation
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. 3M
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. BioTissue
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3 North America biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 5. North America biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 7. U.S. biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 8. U.S. biological skin substitute, by application, 2018 - 2030 (USD Million)
  • Table 9. U.S. biological skin substitute, by end use, 2018 - 2030 (USD Million)
  • Table 10. Canada biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 11. Canada biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 12. Canada biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Mexico biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 14. Mexico biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 15. Mexico biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Europe biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 17. Europe biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 18. Europe biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 19. Europe biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 20. UK biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 21. UK biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 22. UK biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Germany biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 24. Germany biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 25. Germany biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 26. France biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 27. France biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 28. France biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Italy biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 30. Italy biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 31. Italy biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 32. Spain biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 33. Spain biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 34. Spain biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 35. Norway biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 36. Norway biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 37. Norway biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 38. Sweden biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 39. Sweden biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 40. Sweden biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 41. Denmark biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 42. Denmark biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 43. Denmark biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 45. Asia Pacific biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 46. Asia Pacific biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 48. China biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 49. China biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 50. China biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Japan biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 51. Japan biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 53. Japan biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 54. India biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 55. India biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 56. India biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 57. Australia biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 58. Australia biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 59. Australia biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 60. South Korea biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 61. South Korea biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 62. South Korea biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 63. Thailand biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 64. Thailand biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 65. Thailand biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 66. Latin America biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 67. Latin America biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 68. Latin America biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 69. Latin America biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Brazil biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 71. Brazil biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 72. Brazil biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 73. Argentina biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 74. Argentina biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 75. Argentina biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 76. Middle East & Africa biological skin substitute market, by country, 2018 - 2030 (USD Million)
  • Table 77. Middle East & Africa biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 78. Middle East & Africa biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 79. Middle East & Africa biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 80. South Africa biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 81. South Africa biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 82. South Africa biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 83. Saudi Arabia biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 84. Saudi Arabia biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 85. Saudi Arabia biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 86. UAE biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 87. UAE biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 88. UAE biological skin substitute market, by end use, 2018 - 2030 (USD Million)
  • Table 89. Kuwait biological skin substitute market, by type, 2018 - 2030 (USD Million)
  • Table 90. Kuwait biological skin substitute market, by application, 2018 - 2030 (USD Million)
  • Table 91. Kuwait biological skin substitute market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Disposable Syringes Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Biological Skin Substitutes Market, for Type, 2018 - 2030 (USD Million)
  • Fig. 15 Global Biological Skin Substitutes Market, for Human Donor Tissue-derived Products, 2018 - 2030 (USD Million)
  • Fig. 16 Global Biological Skin Substitutes Market, for Acellular Animal-derived Products, 2018 - 2030 (USD Million)
  • Fig. 17 Global Biological Skin Substitutes Market, for Applications, 2018 - 2030 (USD Million)
  • Fig. 18 Global Biological Skin Substitutes Market, for Acute Wounds, 2018 - 2030 (USD Million)
  • Fig. 19 Global Biological Skin Substitutes Market, for Chronic Wounds, 2018 - 2030 (USD Million)
  • Fig. 20 Global Biological Skin Substitutes Market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 21 Global Biological Skin Substitutes Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 22 Global Biological Skin Substitutes Market, for Outpatient Facilities, 2018 - 2030 (USD Million)
  • Fig. 23 Global Biological Skin Substitutes Market, for Research and manufacturing, 2018 - 2030 (USD Million)
  • Fig. 24 Regional Outlook, 2023 & 2030
  • Fig. 25 North America Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 31 UK Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 32 France Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 40 China Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 41 India Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 51 UAE Biological Skin Substitutes Market, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait Biological Skin Substitutes Market, 2018 - 2030 (USD Million)